PRICE T ROWE ASSOCIATES INC /MD/ - CITIUS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$18
-69.5%
25,009
-48.4%
0.00%
Q2 2023$59
+110.7%
48,509
+106.4%
0.00%
Q1 2023$28
+55.6%
23,500
+4.9%
0.00%
Q4 2022$18
-99.9%
22,4000.0%0.00%
Q3 2022$28,000
+33.3%
22,4000.0%0.00%
Q2 2022$21,000
-43.2%
22,400
+7.1%
0.00%
Q1 2022$37,000
+37.0%
20,909
+18.7%
0.00%
Q4 2021$27,000
-32.5%
17,609
-10.2%
0.00%
Q3 2021$40,000
-39.4%
19,609
+3.2%
0.00%
Q2 2021$66,000
+247.4%
19,009
+82.8%
0.00%
Q1 2021$19,000
+72.7%
10,4000.0%0.00%
Q4 2020$11,00010,4000.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Key Bridge Compliance, LLC 154,130$105,4870.03%
CHELSEA COUNSEL CO 81,300$55,6420.03%
Inspire Advisors, LLC 186,410$127,5790.02%
Horst & Graben Wealth Management LLC 75,722$51,8240.01%
GSA CAPITAL PARTNERS LLP 198,492$1360.01%
Arkadios Wealth Advisors 100,000$68,4400.01%
Miller Investment Management, LP 50,000$34,2200.01%
XTX Topco Ltd 29,077$19,9000.00%
Measured Wealth Private Client Group, LLC 10,000$6,8440.00%
Pasadena Private Wealth, LLC 10,965$7,5040.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders